Stromová štruktúra MeSH - hypolipoproteinémie

[c16.320.565.398.500]

• choroby a abnormality novorodenecké, vrodené a dedičné [c16] +
  • choroby genetické, vrodené [c16.320] +
    • poruchy metabolizmu, vrodené [c16.320.565] +
      • poruchy metabolizmu lipidov, vrodené [c16.320.565.398] +
        • Barthov syndróm [c16.320.565.398.224]
        • hyperlipidémia familiárna kombinovaná [c16.320.565.398.450]
        • hyperlipoproteinémia typu I [c16.320.565.398.465]
        • hyperlipoproteinémia typu II [c16.320.565.398.481] +
        • hyperlipoproteinémia typu III [c16.320.565.398.483]
        • hyperlipoproteinémia typu IV [c16.320.565.398.487]
        • hyperlipoproteinémia typu V [c16.320.565.398.493]
        • hypolipoproteinémie [c16.320.565.398.500]
          • hypoalfalipoproteinémie [c16.320.565.398.500.330] +
          • hypobetalipoproteinémie [c16.320.565.398.500.440] +
        • lipidózy [c16.320.565.398.641] +
        • lipodystrofia generalizovaná vrodená [c16.320.565.398.745]
        • Smithov-Lemliho-Opitzov syndróm [c16.320.565.398.850]
        • xantomatóza cerebrotendinózna [c16.320.565.398.925]

[c18.452.584.500.875]

• choroby metabolické a poruchy výživy [c18] +
  • choroby metabolické [c18.452] +
    • poruchy metabolizmu lipidov [c18.452.584] +
      • dyslipidémie [c18.452.584.500] +
        • hyperlipidémie [c18.452.584.500.500] +
        • hypolipoproteinémie [c18.452.584.500.875]
          • hypoalfalipoproteinémie [c18.452.584.500.875.330] +
          • hypobetalipoproteinémie [c18.452.584.500.875.440] +
        • Smithov-Lemliho-Opitzov syndróm [c18.452.584.500.937]

[c18.452.584.563.500]

• choroby metabolické a poruchy výživy [c18] +
  • choroby metabolické [c18.452] +
    • poruchy metabolizmu lipidov [c18.452.584] +
      • poruchy metabolizmu lipidov, vrodené [c18.452.584.563] +
        • Barthov syndróm [c18.452.584.563.224]
        • hyperlipidémia familiárna kombinovaná [c18.452.584.563.450]
        • hyperlipoproteinémia typu I [c18.452.584.563.465]
        • hyperlipoproteinémia typu II [c18.452.584.563.481] +
        • hyperlipoproteinémia typu III [c18.452.584.563.483]
        • hyperlipoproteinémia typu IV [c18.452.584.563.487]
        • hyperlipoproteinémia typu V [c18.452.584.563.493]
        • hypobetalipoproteinémia s deficitom apolipoproteínu B, familiárna [c18.452.584.563.497]
        • hypolipoproteinémie [c18.452.584.563.500]
          • hypoalfalipoproteinémie [c18.452.584.563.500.330] +
          • hypobetalipoproteinémie [c18.452.584.563.500.440] +
        • lipidózy [c18.452.584.563.641] +
        • lipodystrofia generalizovaná vrodená [c18.452.584.563.745]
        • lipodystrofia familiárna čiastočná [c18.452.584.563.798]
        • Shwachmanov-Diamondov syndróm [c18.452.584.563.824]
        • Smithov-Lemliho-Opitzov syndróm [c18.452.584.563.850]
        • xantomatóza cerebrotendinózna [c18.452.584.563.925]

[c18.452.648.398.500]

• choroby metabolické a poruchy výživy [c18] +
  • choroby metabolické [c18.452] +
    • poruchy metabolizmu, vrodené [c18.452.648] +
      • poruchy metabolizmu lipidov, vrodené [c18.452.648.398] +
        • Barthov syndróm [c18.452.648.398.224]
        • hyperlipidémia familiárna kombinovaná [c18.452.648.398.450]
        • hyperlipoproteinémia typu I [c18.452.648.398.465]
        • hyperlipoproteinémia typu II [c18.452.648.398.481] +
        • hyperlipoproteinémia typu III [c18.452.648.398.483]
        • hyperlipoproteinémia typu IV [c18.452.648.398.487]
        • hyperlipoproteinémia typu V [c18.452.648.398.493]
        • hypolipoproteinémie [c18.452.648.398.500]
          • hypoalfalipoproteinémie [c18.452.648.398.500.330] +
          • hypobetalipoproteinémie [c18.452.648.398.500.440] +
        • lipidózy [c18.452.648.398.641] +
        • lipodystrofia generalizovaná vrodená [c18.452.648.398.745]
        • Smithov-Lemliho-Opitzov syndróm [c18.452.648.398.850]
        • xantomatóza cerebrotendinózna [c18.452.648.398.925]